August 20, 2026

Protein degradation rate helps explain why humans develop more slowly than mice

Protein degradation rate helps explain why humans develop more slowly than mice

EMBL researchers have uncovered differences in protein degradation rates between humans and mice that could underlie their different developmental tempos

Researchers at EMBL measured the protein degradation rate of around 4,000 proteins in human and mouse cells. Credit: Daniela Velasco/EMBL

Humans develop at a slower rate than other mammalian species, like mice, but scientists are still trying to understand the molecular basis of these differences. Now, researchers from the Ebisuya Group at EMBL Barcelona and PoL-TU Dresden and from the Savitski Team at EMBL Heidelberg show that across 4,000 proteins shared between humans and mice, there is a clear tendency for protein degradation in humans to be slower than in mice. Protein degradation is the cellular process of breaking down proteins into amino acids. This is a recycling system that keeps cells healthy. During embryo development, protein degradation is important because it contributes to the pace of the segmentation clock. 

The link between protein degradation and the pace of the segmentation clock was already shown in previous work from the Ebisuya Group at EMBL Barcelona: the developmental gene HES7 produces a protein that is degraded more slowly in human cells than in mouse cells, contributing to the slower pace of the human segmentation clock and to embryo development. 

What is the segmentation clock?
The segmentation clock is the oscillatory expression of a group of genes. Each oscillation controls the formation of a pair of body segments. The frequency of the oscillations differs across species, each oscillation taking two to three times longer in humans compared to mice.

In this new study, published in Developmental Cell, the researchers asked whether this difference extends beyond a single gene. They analysed around 4,000 human genes with corresponding mouse counterparts and compared the degradation rates of the proteins encoded by these genes. Although not every protein followed the same pattern – and some were even degraded more slowly in mouse cells – the researchers found a clear overall tendency for proteins to persist longer in human cells.

“Initially, we expected to find a special type of proteins that are degraded differently between species,” said Miki Ebisuya, Group Leader at PoL-TU Dresden, former EMBL Group Leader, and senior author of the work. “Instead, we discovered that slower protein degradation in humans is a general feature across the proteome.”

This trend was not restricted to particular types of proteins or cellular compartments. Proteins with diverse functions showed similar differences, and slower degradation in human cells was observed regardless of whether proteins were broken down through the proteasome or the lysosome – two very different ways of disposing of old proteins. Together, these findings suggest that slower protein degradation is a general property of human cells, rather than a characteristic of specific proteins, providing a unifying explanation for differences in developmental tempo between species.

To investigate what drives this consistent difference, the Ebisuya Group examined the role of cellular metabolism. By reducing metabolic activity in mouse cells, they slowed protein degradation, causing the cells to adopt a degradation and developmental speed that resembled that of human cells. The findings identify metabolism as a key regulator of protein turnover and reveal a link between cellular physiology and developmental timing, offering new insights into how fundamental biological processes shape the pace of life across species.


Source article(s)

Systematic differences in protein stability underlie species-specific developmental tempo.

Matsuda M., et al.

Developmental Cell 13 August 2026

https://doi.org/10.1016/j.devcel.2026.07.012

Our latest News

discover more
Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

More Information HEIDELBERG, Germany, September 30, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company specializing in blood-based small RNA analysis for precision oncology, today announced that data from a new collaborative study will be presented at the ESMO Congress 2026 in Madrid, Spain. Building on Hummingbird’s expertise in early cancer detection, the study explores […]

Greater Precision and Safety in Neurosurgical Procedures

Greater Precision and Safety in Neurosurgical Procedures

A new surgical system at the Department of Neurosurgery at Heidelberg University Hospital helps surgeons precisely plan procedures on the brain, spine, and skull base, monitor them during surgery, and perform them with millimeter precision. The “Robotic Surgery Suite,” which cost approximately 1.6 million euros, combines live imaging, digital navigation, and robotic assistance directly in […]

Mitochondrial Protein Complexes: A Single Amino Acid Can Jeopardize Their Stability

Mitochondrial Protein Complexes: A Single Amino Acid Can Jeopardize Their Stability

Scientists from Heidelberg and Freiburg identify the mechanism by which proteins assemble into stable complexes in mitochondria A tiny processing step has far-reaching consequences for mitochondrial function: The removal of a single amino acid determines whether new proteins can assemble into stable complexes within these cellular powerhouses. This process is carried out by a specific […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp